FDA finds data integrity, sterility problems at Indian drugmaker

Regulatory NewsRegulatory NewsCDERComplianceGMPOTCPharmaceuticalsQuality Assurance and ControlRecallsRegulatory Intelligence/PolicyUnited StatesWarning letters